UK – FTSE has announced the creation of a new index, FTSE techMARK mediscience, designed to reflect the market performance of growth companies listed on the London Stock Exchange’s (LSE) new market, techMARK mediscience.
The new index will begin calculation when the market opens tomorrow (November 2).
The new index forms part of the FTSE techMARK Index Series, and will be reviewed quarterly, by an independent Committee of market users.
Mark Makepeace, FTSE’s chief executive comments: “The FTSE Group designs and calculates indices for investors worldwide and covers specialist as well as mainstream markets. We believe in innovation, and are committed to developing initiatives in response to market demand, so it’s a natural step for FTSE to create an index to support techMARK mediscience.”
Martin Wheatley, deputy CEO, London Stock Exchange said “The mediscience industry attracts a lot of interest – from issuers, investors, intermediaries and the media alike. By providing focus, techMARK mediscience will draw liquidity to this new market and make investment decisions easier.”